Dimerix LimitedASX: DXB

Notification of 2026 Annual General Meeting Date

Sep 25, 2026 at 12:42 AM EDT · Issued by Dimerix Limited via ASX

Filed with ASX · Sep 25, 2026 at 12:42 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/notification-of-2026-annual-general-meeting-date

Release

Dimerix is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. Dimerix HQ 425 Smith St, Fitzroy 3065 Victoria, Australia T. 1300 813 321 E. [email protected] For Immediate Release NOTIFICATION OF 2026 ANNUAL GENERAL MEETING DATE MELBOURNE,...

Dimerix Limited on 6ix

Earlier from Dimerix

Dimerix Draws Down A$17M Under Non-Dilutive Funding FacilitySep 22
Dimerix Presents at ASX SMIDcaps Conference 2026Sep 22
Waiver of Listing Rule 10.1 GrantedSep 22
Dimerix Presents at E&P Healthcare Conference 2026Sep 15
Dimerix DMX-652 Granted Mexican Composition of Matter PatentSep 13

Later from Dimerix

Notification regarding unquoted securities - DXBSep 28
First Patient Reaches Four Years in DMX-200 Clinical ProgramOct 4
Dimerix at Canaccord Drug & Device and Ignite ConferencesOct 11
DMX-200 First 100 Patients Complete Phase 3 Trial TreatmentOct 15
Dimerix Announces Board Chair TransitionOct 18

All Dimerix news releases

Follow Dimerix into a list and get an email when it puts out news.

Follow Dimerix